Posts

Beyond Weight Loss: Could Popular GLP-1 Drugs Like Ozempic Help Keep Asthma Attacks at Bay?

Tezepelumab in Real-World Danish Severe Asthma Study: Benefits Even After Biologic Switches

Tezepelumab vs. Dupilumab in Severe Asthma: Head-to-Head Real-World Data Shows No Clear Winner

Biologic Management in Severe Asthma for Adults - New Guideline by CHEST in 2026

"Pseudo leukotrienes" øLTs - new inflammation-triggering molecules - may play a role in asthma

The Interplay Between Obesity and Asthma

Addressing Upper Airway Comorbidities: A Key Strategy in Asthma Management

SABA/ICS prn combo for asthma: AIRSUPRA (albuterol/budesonide)

Asthma (#ACAAI19 Twitter summary)

Good News: FDA-Approved Generic of Albuterol Inhaler Available for $23 as of April 2020

Cost of anti-IL biologics in US as of 2019

Dupilumab (Dupixent) dose for asthma: when do you use 200 mg vs. 300 mg?

Currently available biologic therapies (biologics) for asthma

Time for a paradigm shift in asthma guidelines: tools to monitor asthma across the lifespan

Game Changer: Dupilumab Injections for Uncontrolled Asthma

May 1st is World Asthma Day: use CDC Toolkit to take control of and raise awareness about asthma

The VOCs danger: Everyday products such as perfume, skin lotion, hair spray, deodorant, household cleaners are a top source of air pollution

Preschool Recurrent Wheezing and Asthma

COPD, ACO and the Chronic Airflow Obstruction Phenotype - 2018 WSAAI update

Rhinovirus-Induced Asthma Exacerbations - 2018 WSAAI update